Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Delaware News Ledger.
Press releases published on May 30, 2025

QFSCOIN Offers Global Crypto Investors Opportunity to Earn Bitcoin as Passive Income with Free Cloud Mining
Wilmington, Delaware, May 30, 2025 (GLOBE NEWSWIRE) -- As Bitcoin continues to gain attention in 2025, and Dogecoin shows renewed momentum, resourceful investors are exploring avenues to potentially earn without significant capital at risk. QFSCOIN offers …

Yuki Releases First Industry Guide to Snowflake Optimization, Helping Data Teams Save 30-60% Without Manual Tuning
SAN FRANCISCO, May 30, 2025 (GLOBE NEWSWIRE) -- Yuki, the leader in automated cost optimization for Snowflake, has released its first flagship gated asset: The Ultimate Guide to Snowflake Optimization (2025 Edition), a hands-on playbook for data teams, …

Questex Travel Group Unveils Strategic Rebrand Amid Unprecedented Travel Industry Surge
NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Questex’s Travel Group, the leading provider of business information and events for the travel industry, today announces a strategic rebranding aimed at unifying its portfolio under a cohesive vision that reflects …

QFSCOIN Launches Affordable Cloud Mining Contracts to Democratize Bitcoin Access
Lewes, Delaware, May 30, 2025 (GLOBE NEWSWIRE) -- QFSCOIN, a Delaware-based regulated cloud mining platform, today announced the launch of its affordable Bitcoin, Litecoin, and Dogecoin cloud mining contracts—eliminating the traditional barriers of cost, …

Aimfinity Investment Corp. I Announces Transition from Nasdaq to OTC Markets and New Monthly Extension for Business Combination
Wilmington, DE, May 30, 2025 (GLOBE NEWSWIRE) -- Aimfinity Investment Corp. I (the “AIMA”) (Nasdaq: AIMTF), a special purpose acquisition company incorporated as a Cayman Islands exempted company, today announced that, in order to extend the date by which …

Zymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract Cancer
Zanidatamab is the first and only dual HER2-targeted bispecific antibody approved for HER2+ biliary tract cancer in China; conditional approval based on the results of the HERIZON-BTC-01 clinical study $20 million milestone payment to be received from …

Best VPN for Streaming (2025): IPVanish Recognized as Top Streaming VPN by Software Experts
NEW YORK CITY, May 30, 2025 (GLOBE NEWSWIRE) -- Software Experts has recognized IPVanish as the Best VPN for Streaming in 2025, citing its strong performance across speed, server coverage, privacy features, and usability. The review highlights IPVanish’s …